Shopping Cart
- Remove All
- Your shopping cart is currently empty
(S)-PHA533533, a cyclin-dependent kinase 2 (CDK2) inhibitor, exhibits antitumor activity and has the capability to induce widespread expression of UBE3A in neurons of Angelman syndrome model mice.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | (S)-PHA533533, a cyclin-dependent kinase 2 (CDK2) inhibitor, exhibits antitumor activity and has the capability to induce widespread expression of UBE3A in neurons of Angelman syndrome model mice. |
Molecular Weight | 338.40 |
Formula | C19H22N4O2 |
Cas No. | 437982-89-3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.